TULOVI Trademark

Trademark Overview


On Wednesday, April 17, 2024, a trademark application was filed for TULOVI with the United States Patent and Trademark Office. The USPTO has given the TULOVI trademark a serial number of 98504382. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, October 30, 2024. This trademark is owned by KVR Pharmaceuticals Inc.. The TULOVI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of metabolic, hemorrhagic, endocrine, genitourinary, oncological, hepatological and hormonal related diseases and disorders
tulovi

General Information


Serial Number98504382
Word MarkTULOVI
Filing DateWednesday, April 17, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations and substances for the treatment of metabolic, hemorrhagic, endocrine, genitourinary, oncological, hepatological and hormonal related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKVR Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5P1S2
CA

Trademark Events


Event DateEvent Description
Wednesday, April 17, 2024NEW APPLICATION ENTERED
Wednesday, April 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 30, 2024ASSIGNED TO EXAMINER
Wednesday, October 30, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 30, 2024NON-FINAL ACTION E-MAILED